ema semaglutide naion june 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden vision loss known as non-arteritic anterior ischemic optic neuropathy ( Ischemic Optic Neuropathy: Causes, Symptoms,

Type 2 diabetes itself confers increased thrombotic risk through multiple mechanisms, including hyperglycaemia-induced endothelial damage, increased platelet reactivity, elevated coagulation factors, and reduced fibrinolysis

In these animals, artificial elevation of the innate immune response either through a genetic mechanism or via exposure to a virus mimics results in significant melanocyte and melanocyte stem cell loss and leads to the production of an increased number of gray hairs

[87] Anthenelli RM, Benowitz NL, West R, et al

Administration: Tirzepatide should be administered once weekly via subcutaneous injection at consistent times

Addressing Common Concerns and Misconceptions Addressing common concerns and misconceptions about injectable medications is also important